Exchange: NSE Sector: Healthcare Industry: Diagnostics & Research
0.03% INR2 323.40
America/New_York / 8 mai 2024 @ 05:15
FUNDAMENTALS | |
---|---|
MarketCap: | 192 701 mill |
EPS: | 39.62 |
P/E: | 58.64 |
Earnings Date: | May 09, 2024 |
SharesOutstanding: | 82.94 mill |
Avg Daily Volume: | 0.253 mill |
RATING 2024-05-08 |
---|
A+ |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Buy | |
Return On Asset: | Neutral | |
DE: | Sell | |
P/E: | Strong Buy | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | n/a | n/a | n/a | |||
Debt | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 58.64 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 58.64 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
INR3 084.27 (32.75%) INR760.87 |
Date: 2024-05-08 |
Expected Trading Range (DAY) |
---|
INR 2 257.54 - 2 379.06 ( +/- 2.62%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | INR2 323.40 (0.03% ) |
Volume | 0.0939 mill |
Avg. Vol. | 0.253 mill |
% of Avg. Vol | 37.15 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.